Cargando…
Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy
We have developed a theranostic nanoparticle, ie, cet-PEG-dexSPIONs, by conjugation of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody, cetuximab, to dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) via periodate oxidation. Approximately 31 antibody molecules w...
Autores principales: | Tseng, Shih-Heng, Chou, Min-Yuan, Chu, I-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445874/ https://www.ncbi.nlm.nih.gov/pubmed/26056447 http://dx.doi.org/10.2147/IJN.S80134 |
Ejemplares similares
-
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
por: Kaluzova, Milota, et al.
Publicado: (2015) -
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
por: Sihver, Wiebke, et al.
Publicado: (2014) -
Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
por: Qian, Yichun, et al.
Publicado: (2014) -
Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells
por: El Hallal, Ralph, et al.
Publicado: (2021) -
Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
por: Thomas, Reju, et al.
Publicado: (2013)